These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8763048)

  • 1. [Antacid activity of citrate-bicarbonate complex of effervescent formulations of ranitidine. In vitro analysis using 'artificial stomach-duodenum' model].
    Vatier J; Cai S; Slama A; Farinotti R
    Therapie; 1996; 51(2):139-46. PubMed ID: 8763048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro assessment of antacid efficacy using a computer-controlled 'artificial stomach-duodenum' model reproducing gastroduodenal flux regulation.
    Vatier J; Cai S; Célice-Pingaud C; Castela-Papin N; Mignon M; Farinotti R
    Therapie; 1996; 51(2):147-54. PubMed ID: 8763049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antacid activity of calcium carbonate and hydrotalcite tablets. Comparison between in vitro evaluation using the "artificial stomach-duodenum" model and in vivo pH-metry in healthy volunteers.
    Vatier J; Ramdani A; Vitré MT; Mignon M
    Arzneimittelforschung; 1994 Apr; 44(4):514-8. PubMed ID: 8011006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An artificial stomach-duodenum model for the in-vitro evaluation of antacids.
    Vatier J; Malikova-Sekera E; Vitre MT; Mignon M
    Aliment Pharmacol Ther; 1992 Aug; 6(4):447-58. PubMed ID: 1420737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of antacid characteristics of drugs containing a combination of aluminium and magnesium salts using the "artificial stomach" model.
    Vatier J; Vitre MT; Lionnet F; Poitevin C; Mignon M
    Arzneimittelforschung; 1990 Jan; 40(1):42-8. PubMed ID: 2339999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of ranitidine effervescent tablets and magnesium hydroxide-aluminium oxide on intragastric acidity. A single-centre, randomised, open cross-over study.
    Propst A; Propst T; Judmaier G
    Arzneimittelforschung; 1996 Jun; 46(6):621-4. PubMed ID: 8767354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of cimetidine and ranitidine with aluminum-containing antacids and a clay-containing gastric-protective drug in an "artificial stomach-duodenum" model.
    Vatier J; Harman A; Castela N; Droy-Lefaix MT; Farinotti R
    J Pharm Sci; 1994 Jul; 83(7):962-6. PubMed ID: 7965675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro evaluation of antacid activity in gastric acid secretion in static and dynamic systems].
    Vatier J; Malikova-Sekera E; Vitre MT; Mignon M
    Therapie; 1992; 47(2):99-104. PubMed ID: 1412150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the antacid properties of Gelox in a dynamic milieu using the artificial stomach apparatus].
    Vatier J; Vitre MT; Lionnet F; Mignon M
    Therapie; 1989; 44(1):43-8. PubMed ID: 2734720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [pH gradient support and antacid action of gastroesophageal coating agents. In vitro pharmacologic study using a model of "the artificial stomach"].
    Vatier J; Vitre MT; Vallot T; Mignon M
    Gastroenterol Clin Biol; 1990; 14(5):414-22. PubMed ID: 2163935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interests of the 'artificial stomach' techniques to study antacid formulations: comparison with in vivo evaluation.
    Vatier J; Célice-Pingaud C; Farinotti R
    Fundam Clin Pharmacol; 1998; 12(6):573-83. PubMed ID: 9818289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficacy of Alka-Seltzer Effervescent in gastric acid neutralization.
    Chen CT; Toung TJ; Haupt HM; Hutchins GM; Cameron JL
    Anesth Analg; 1984 Mar; 63(3):325-9. PubMed ID: 6703349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onset of action of antisecretory drugs: beneficial effects of a rapid increase in intragastric pH in acid reflux disease.
    Pipkin GA; Mills JG
    Scand J Gastroenterol Suppl; 1999; 230():3-8. PubMed ID: 10499455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effervescent and standard formulations of ranitidine--a comparison of their pharmacokinetics and pharmacology.
    Watson RG; Johnston BT; Tham TC; Kersey K
    Aliment Pharmacol Ther; 1996 Dec; 10(6):913-8. PubMed ID: 8971288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation of intelligent tablets with an antacid effect.
    Bajdik J; Korbely A; Pintye-Hódi K
    Pharm Dev Technol; 2009; 14(5):471-5. PubMed ID: 19552554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approach for the in vitro evaluation of antacids.
    Vatier J; Vallot T; Vitre MT; Mignon M
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):175-9. PubMed ID: 2185759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intragastric pH rise with effervescent citrate-cimetidine.
    Ström M; Madsen S; Norlander B
    Lancet; 1991 Feb; 337(8738):433. PubMed ID: 1671456
    [No Abstract]   [Full Text] [Related]  

  • 18. Does twice the volume of antacid have twice the effect in pregnant women at term?
    O'Sullivan GM; Bullingham RE
    Anesth Analg; 1984 Aug; 63(8):752-6. PubMed ID: 6465561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model of an 'artificial stomach' for assessing the characteristics of an antacid.
    Vatier J; Lionnet F; Vitré MT; Mignon M
    Aliment Pharmacol Ther; 1988 Oct; 2(5):461-70. PubMed ID: 2979268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of magaldrate antacid efficacy in the presence of some drugs and its effect on their dissolution rates: Part I.
    al Gohary OM
    Boll Chim Farm; 1996 Dec; 135(11):621-37. PubMed ID: 9066172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.